CME Group Announces New Regional Leadership Structure to Strengthen Focus on International Business Growth and Facilitate Enhanced Service to Clients Outside the United States
CME Group announced a new regional leadership structure to enhance its international operations in EMEA and Asia Pacific. This change aims to improve local expertise and service offerings in response to growing revenue from non-U.S. markets—approximately 30% of total revenue. Key appointments include Michel Everaert as Managing Director for EMEA and Russell Beattie for Asia Pacific. In Q1 2022, CME Group achieved a record average daily volume of 7.3 million contracts outside the U.S., marking an 18% year-on-year growth. The organizational changes reflect the company’s commitment to its expanding international business.
- 30% of revenue now generated from non-U.S. markets.
- Q1 2022 reported average daily volume (ADV) of 7.3 million contracts, an 18% increase year-on-year.
- EMEA ADV rose 17% to 5.1 million contracts; Asia Pacific ADV increased 22% to 1.9 million contracts.
- Retirement of William Knottenbelt, Head of International, could create transition challenges.
CHICAGO, LONDON and SINGAPORE, April 12, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced a new regional leadership structure to support its growing international business in Europe, Middle East and Africa (EMEA) and Asia Pacific.
The new structure is designed to enhance the company's ability to provide local expertise and globally relevant products and services that meet the diverse risk management needs of its clients around the world. Reporting to Derek Sammann, Senior Managing Director, Global Head of Commodities, Options and International Markets and a member of the CME Group Management Team, the following executives have been appointed to new roles:
- Michel Everaert, has been named Managing Director and Head of EMEA, a new position based in London. Everaert joined CME Group in 2011 and most recently served as the company's Managing Director and Co-Head of Client Development & Sales (CD&S) for EMEA. He has 30 years of experience in derivatives markets including roles at IMEX Group, GFI Group, Logica, Reuters and Dow Jones.
- Russell Beattie will join CME Group in May as Managing Director and Head of Asia Pacific. Based in Singapore, Beattie has over 25 years of experience in the listed and OTC derivatives markets and most recently served as Head of Asia Pacific Derivatives Indexes for MSCI. He also held APAC leadership roles for Bank of America Securities, Barclays, Deutsche Bank and HSBC. He replaces Chris Fix who retired in March 2022.
Additionally, Serge Marston has been appointed Managing Director and Head of CD&S for EMEA, responsible for leading CME Group's sales efforts in the region across both listed derivatives and cash markets. Marston will be based in London and will report to David Hartney, Global Head of CD&S. Marston joined CME Group in 2018 following the company's acquisition of NEX Group and most recently served as Co-Head of CD&S for EMEA. Marston previously worked at Deutsche Bank for nearly 20 years where he held a variety of roles including Global Head of eCommerce Sales.
William Knottenbelt, who currently serves as Senior Managing Director, Head of International, will retire at yearend.
"After record volume growth in EMEA and Asia Pacific for each of the past 10 years, approximately
"I'm now pleased to appoint Michel Everaert, who is a long-standing CME Group employee, to head our EMEA region and name Russell Beattie to lead our business in Asia Pacific. Our new structure will enhance our ability to provide local expertise and globally relevant products and services to meet the diverse risk management needs of our clients around the world."
In Q1 2022, outside the United States, CME Group reached average daily volume (ADV) of 7.3 million contracts, up
In 2021, CME Group saw a record ADV of 5.5 million contracts from outside of the U.S., representing
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners.
CME-G
View original content:SOURCE CME Group
FAQ
What is the new leadership structure announced by CME on April 12, 2022?
Who are the key appointments in CME Group's new leadership structure?
How much revenue does CME Group generate from non-U.S. markets?
What was CME Group's average daily volume in Q1 2022?
What growth did CME Group see in EMEA and Asia Pacific in Q1 2022?
